1
00:00:00,360 --> 00:00:03,280
Speaker 1: Jonesy and Amanda's Well.

2
00:00:03,320 --> 00:00:06,640
Speaker 2: Since COVID first up ended in our lives, a vaccine

3
00:00:06,680 --> 00:00:09,880
Speaker 2: has really been our only hope to open up all

4
00:00:09,920 --> 00:00:13,520
Speaker 2: our borders between US and the States, as well as

5
00:00:13,560 --> 00:00:17,320
Speaker 2: traveling overseas. Finally, the phires A vaccine has been approved

6
00:00:17,320 --> 00:00:19,919
Speaker 2: for use in Australia. But what does it all mean?

7
00:00:20,120 --> 00:00:22,279
Speaker 2: Will everyone get it? How long will all this take?

8
00:00:22,320 --> 00:00:24,440
Speaker 2: How effective is it? We thought we'd go to our

9
00:00:24,440 --> 00:00:28,720
Speaker 2: infectious disease as specialist doctor Sanjayasen and Yaki, who's here

10
00:00:28,720 --> 00:00:31,160
Speaker 2: to answer all our tricky questions. Good morning, doctor?

11
00:00:33,440 --> 00:00:35,159
Speaker 3: Do we get a lollipop at the end of it?

12
00:00:35,280 --> 00:00:37,800
Speaker 1: Doc? I want the lollipop.

13
00:00:38,400 --> 00:00:40,279
Speaker 2: Imagine if you've got a lollipop every time you had

14
00:00:40,280 --> 00:00:44,880
Speaker 2: to administer anything, your teeth would be out by now. Well,

15
00:00:45,040 --> 00:00:48,320
Speaker 2: the Phiza vaccine has been approved for use in Australia.

16
00:00:48,360 --> 00:00:50,839
Speaker 2: There were various ones that we could have gone with.

17
00:00:50,960 --> 00:00:52,480
Speaker 2: Are we happy? Is this the best option?

18
00:00:53,840 --> 00:00:57,240
Speaker 1: Look, Amanda, the fire vaccine is very good. It's gone

19
00:00:57,280 --> 00:01:03,040
Speaker 1: through a rigorous, transparent three trial and it's being shown

20
00:01:03,280 --> 00:01:06,919
Speaker 1: to not only be safe but very effective as well.

21
00:01:07,160 --> 00:01:10,679
Speaker 1: And we're not seeing any major issues in the rollout globally.

22
00:01:10,800 --> 00:01:15,080
Speaker 1: So we've now surpassed one hundred million people being vaccinated

23
00:01:15,120 --> 00:01:18,560
Speaker 1: outside clinical trials for COVID, So we're getting a good

24
00:01:18,600 --> 00:01:22,399
Speaker 1: idea about how safe and efficacious these vaccines are under

25
00:01:22,480 --> 00:01:23,399
Speaker 1: real world have a.

26
00:01:23,480 --> 00:01:25,560
Speaker 2: Hundred how many people have been vaccinated?

27
00:01:26,400 --> 00:01:29,040
Speaker 1: So yeah, now it's just over one hundred million.

28
00:01:29,240 --> 00:01:29,880
Speaker 3: Wow.

29
00:01:30,319 --> 00:01:34,160
Speaker 1: Yeah, So in absolute numbers, the US is leading the way,

30
00:01:34,240 --> 00:01:37,840
Speaker 1: but in terms of the proportion of the population, Israel

31
00:01:38,120 --> 00:01:39,520
Speaker 1: is miles ahead of everyone.

32
00:01:39,760 --> 00:01:42,280
Speaker 3: I was reading a story about when the Spanish flu

33
00:01:42,400 --> 00:01:46,360
Speaker 3: went through in nineteen eighteen, nineteen nineteen, they were rolling

34
00:01:46,360 --> 00:01:48,920
Speaker 3: out their vaccine around about now, but they were using

35
00:01:49,120 --> 00:01:53,000
Speaker 3: glass syringes with reusable needles on people.

36
00:01:54,840 --> 00:01:58,200
Speaker 1: Oh look absolutely, I mean one hundred years ago. In

37
00:01:58,280 --> 00:02:02,000
Speaker 1: terms of vaccine development administration. It really was the sort

38
00:02:02,000 --> 00:02:05,480
Speaker 1: of prehistoric dark ages. We've just come so far since then,

39
00:02:05,640 --> 00:02:06,560
Speaker 1: it's amazing.

40
00:02:06,760 --> 00:02:09,040
Speaker 2: So how will it be rolled out? Will it be

41
00:02:09,600 --> 00:02:12,359
Speaker 2: frontline workers, the elderly? How's it going to happen?

42
00:02:13,840 --> 00:02:18,040
Speaker 1: Yees. So we've got a few phases in the Australian programs.

43
00:02:18,040 --> 00:02:21,160
Speaker 1: In the Phase one A, one B, two A, two

44
00:02:21,200 --> 00:02:24,360
Speaker 1: B and three and Phase one A involves about just

45
00:02:24,480 --> 00:02:28,160
Speaker 1: under seven hundred thousand people, and the other four phases

46
00:02:28,680 --> 00:02:32,000
Speaker 1: involve about six million people each, And as he correctly said,

47
00:02:32,040 --> 00:02:34,560
Speaker 1: the Phase one A, which is the first one, which

48
00:02:34,600 --> 00:02:37,079
Speaker 1: involves about six hundred and seventy six hundred and eighty

49
00:02:37,080 --> 00:02:42,040
Speaker 1: thousand people, quarantine and border workers, frontline healthcare workers, age

50
00:02:42,080 --> 00:02:46,920
Speaker 1: care disability staff, and age care disability residents will be

51
00:02:47,080 --> 00:02:48,240
Speaker 1: getting the vaccine.

52
00:02:49,080 --> 00:02:52,880
Speaker 2: The thing I'm intrigued with is if I have the vaccine,

53
00:02:53,840 --> 00:02:56,520
Speaker 2: I'm immune for whatever period of time, And we'll talk

54
00:02:56,520 --> 00:02:59,600
Speaker 2: about that in a second. Am I free to go

55
00:02:59,639 --> 00:03:03,240
Speaker 2: any where places where people aren't vaccinated. Do we need

56
00:03:03,360 --> 00:03:05,840
Speaker 2: herd immunity like we do with measles for example?

57
00:03:06,560 --> 00:03:10,560
Speaker 1: You look, the tricky thing, Amanda, with the vaccine trials

58
00:03:10,760 --> 00:03:14,559
Speaker 1: is when we talk about the ninety five percent efficacy

59
00:03:14,800 --> 00:03:17,840
Speaker 1: with the fires of vaccine in sixty two cent with

60
00:03:17,960 --> 00:03:22,000
Speaker 1: the Oxford et cetera, we're talking about their effectiveness in

61
00:03:22,080 --> 00:03:26,919
Speaker 1: stopping people from getting sick with COVID, So they didn't specifically,

62
00:03:26,960 --> 00:03:30,320
Speaker 1: the trials weren't geared to look at if the vaccine

63
00:03:30,400 --> 00:03:35,080
Speaker 1: stopped transmission of infection. And that's the tricky which they're

64
00:03:35,080 --> 00:03:37,360
Speaker 1: trying to tease out at the moment, and hopefully in

65
00:03:37,400 --> 00:03:40,600
Speaker 1: the next few weeks we'll have a better answer about that.

66
00:03:40,640 --> 00:03:42,640
Speaker 1: So in other words, you might not get really sick

67
00:03:42,720 --> 00:03:45,040
Speaker 1: or sick at all for being vaccinated, but you might

68
00:03:45,120 --> 00:03:46,480
Speaker 1: still be able to give it to someone.

69
00:03:46,840 --> 00:03:49,400
Speaker 3: The Oxford vaccine was one that was the great White hope,

70
00:03:49,400 --> 00:03:51,520
Speaker 3: and it was the fires vaccine in the early days

71
00:03:51,520 --> 00:03:53,640
Speaker 3: that everyone was a bit iffy about. So it seems

72
00:03:53,640 --> 00:03:54,640
Speaker 3: to be the other way around.

73
00:03:55,800 --> 00:03:59,720
Speaker 1: Yeah, that's right. I think the Oxford vaccine, they're sort

74
00:03:59,720 --> 00:04:03,600
Speaker 1: of early trial results were a bit confusing, and the

75
00:04:03,640 --> 00:04:07,960
Speaker 1: efficacy results weren't quite as good as the Fiser one.

76
00:04:08,000 --> 00:04:10,040
Speaker 1: And of course the thing with the Pisa one and

77
00:04:10,120 --> 00:04:13,320
Speaker 1: the Maderna one is their new vaccine technology. So these

78
00:04:13,560 --> 00:04:17,960
Speaker 1: are the first commercially available vaccines using this mRNA technology.

79
00:04:18,360 --> 00:04:21,080
Speaker 1: But it's really good to see how safe and effective

80
00:04:21,560 --> 00:04:22,200
Speaker 1: they seem to be.

81
00:04:22,520 --> 00:04:25,839
Speaker 2: So we see a future then where we all the

82
00:04:25,880 --> 00:04:29,120
Speaker 2: whole nation would be vaccinated every year or something like that.

83
00:04:30,600 --> 00:04:34,640
Speaker 1: Look, so you've brought up the very pertinent issue which

84
00:04:34,680 --> 00:04:37,240
Speaker 1: we don't know the answer to about how long do

85
00:04:37,320 --> 00:04:39,760
Speaker 1: we have immunity from the vaccines. Of course, because these

86
00:04:39,839 --> 00:04:42,960
Speaker 1: vaccine trials have been going for less than a year.

87
00:04:43,000 --> 00:04:45,320
Speaker 1: We don't really know how long they last for. We

88
00:04:45,320 --> 00:04:48,280
Speaker 1: can say they last for this period, which is less

89
00:04:48,279 --> 00:04:50,400
Speaker 1: than a year, but will it last for one year,

90
00:04:50,480 --> 00:04:52,440
Speaker 1: two years, five years or not. And you're quite right,

91
00:04:52,760 --> 00:04:55,520
Speaker 1: we might have to get a booster every one year

92
00:04:55,600 --> 00:04:58,480
Speaker 1: or two years, and as the virus mutates within with

93
00:04:58,520 --> 00:05:00,800
Speaker 1: the South African strain, except sure, we might have to

94
00:05:00,839 --> 00:05:02,080
Speaker 1: adjust it as well.

95
00:05:02,440 --> 00:05:03,720
Speaker 3: And would that mean that you'd have to get a

96
00:05:03,720 --> 00:05:05,880
Speaker 3: flu shot as well? So you get a flu shot

97
00:05:05,920 --> 00:05:08,000
Speaker 3: and a covid vaccine.

98
00:05:08,240 --> 00:05:13,120
Speaker 1: So they're completely different infections. So I can't imagine that

99
00:05:13,160 --> 00:05:17,279
Speaker 1: we'll ever stop doing the flu vaccine because of covid, although,

100
00:05:17,560 --> 00:05:20,560
Speaker 1: as a lot of listeners know, last year, because I

101
00:05:20,600 --> 00:05:23,279
Speaker 1: think of the physical distancing and some other reasons, we

102
00:05:23,360 --> 00:05:24,599
Speaker 1: didn't see much flu at all.

103
00:05:25,839 --> 00:05:28,400
Speaker 2: So does it matter that I've read something recently that

104
00:05:28,440 --> 00:05:31,159
Speaker 2: said like forty percent of Australians are still iffy about

105
00:05:31,200 --> 00:05:33,479
Speaker 2: whether they'll take it. Does that matter.

106
00:05:35,080 --> 00:05:39,239
Speaker 1: To achieve now, assuming that those percentages we talked about

107
00:05:39,240 --> 00:05:43,760
Speaker 1: the efficacies were turn out to apply to transmission of

108
00:05:43,800 --> 00:05:46,800
Speaker 1: the virus after people have been vaccinated, it's a ninety

109
00:05:46,839 --> 00:05:49,960
Speaker 1: five percent efficacy. That's the case. We still want to

110
00:05:49,960 --> 00:05:55,200
Speaker 1: see a number of about sixty percent of people vaccinated

111
00:05:55,440 --> 00:05:59,039
Speaker 1: successfully against this virus, so you know, we definitely want

112
00:05:59,040 --> 00:06:02,080
Speaker 1: as many people as possible to get immunized. And I

113
00:06:02,120 --> 00:06:05,479
Speaker 1: do understand why people would be a bit nervous with

114
00:06:05,560 --> 00:06:09,800
Speaker 1: this vaccine rollout because it's been unprecedentedly unprecedented in terms

115
00:06:09,800 --> 00:06:13,160
Speaker 1: of its quickness, but it hasn't been reckless, and I

116
00:06:13,200 --> 00:06:17,240
Speaker 1: think it's really important to continue being open, transparent and

117
00:06:17,360 --> 00:06:19,479
Speaker 1: having messaging about the vaccination program.

118
00:06:19,640 --> 00:06:21,400
Speaker 3: There it is, so we'll be down to our undies

119
00:06:21,440 --> 00:06:23,720
Speaker 3: and our single it waiting for our lollipop and our

120
00:06:23,839 --> 00:06:27,719
Speaker 3: jab not necessarily in that order, doctor saying thank you

121
00:06:27,760 --> 00:06:29,280
Speaker 3: for joining us, Thank you so much.

122
00:06:29,920 --> 00:06:33,600
Speaker 1: Oh it's a pleasure anytime. Jonesy and Amanda's gamation